Six mutual fund NFOs or new fund offers will open for subscription this week. Should you invest in these NFOs to maximise the return of your portfolio?
DSP Mutual Fund announced the launch of the DSP Multicap Fund. The scheme opened for public subscription on January 08, 2024, and will close on January 22, 2024.
Large-cap pharma players Dr Reddy’s, Cipla, Lupin and Sun Pharma all reported strong growth in the US market in the April-June quarter, with the generics segment faring better than Street expectations. We take a deep dive into the reasons for this turnaround.
Healthcare sector performed well through the early phase of Covid, and as such, returns were high in that period. What we have seen is a correction for some time post that stellar initial performance. However, even earnings performance for the larger pharma companies has been weak in the past few quarters driven by weak margins.